CSL (OTCMKTS:CSLLY) Shares Gap Down - Should You Sell?

Shares of CSL Limited Sponsored ADR (OTCMKTS:CSLLY - Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $79.41, but opened at $76.99. CSL shares last traded at $77.21, with a volume of 3,739 shares changing hands.

CSL Stock Performance

The company has a current ratio of 1.86, a quick ratio of 0.85 and a debt-to-equity ratio of 0.45. The business has a fifty day simple moving average of $78.71 and a 200 day simple moving average of $81.54.

CSL Company Profile

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.